NPR logo

Neurontin Lawsuit

  • Download
  • <iframe src="https://www.npr.org/player/embed/1145205/145205" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
Neurontin Lawsuit

Neurontin Lawsuit

Neurontin Lawsuit

  • Download
  • <iframe src="https://www.npr.org/player/embed/1145205/145205" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

A whistleblower lawsuit alleges that the drug company Parke-Davis devised an illegal strategy to market its anti-epilepsy drug Neurontin for unapproved uses. The suit claims the company gave lavish financial rewards to doctors to create a blockbuster drug. NPR's Snigdha Prakash reports.

We no longer support commenting on NPR.org stories, but you can find us every day on Facebook, Twitter, email, and many other platforms. Learn more or contact us.